ArticleMolecular therapy oncolytics2020

Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination.

Zhiwu Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.